Suppr超能文献

肝素结合生长因子-1对纤溶酶原激活物抑制剂-1表达的调节。与环磷酸腺苷及蛋白激酶C介导途径的相互作用。

Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.

作者信息

Konkle B A, Kollros P R, Kelly M D

机构信息

Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

出版信息

J Biol Chem. 1990 Dec 15;265(35):21867-73.

PMID:1701436
Abstract

Plasminogen activator inhibitor-1 (PAI-1) inhibits the tissue plasminogen activator (tPA) and urokinase activation of plasminogen to plasmin, a protease of trypsin-like specificity which is involved in a number of processes, including fibrinolysis, matrix degradation and angiogenesis. Both phorbol esters and cAMP elevating compounds have been shown to modulate PAI-1 and tPA expression in endothelial cell culture. HBGF-1 (previously designated endothelial cell growth factor) stimulates endothelial cell growth in vitro and is angiogenic in vivo. We have reported that removal of HBGF-1 from human umbilical vein endothelial cell (HUVEC) media results in an approximately 5-fold increase in PAI-1 mRNA levels and in PAI-1 protein secreted into the media by 20 h. Here we report the effects of HBGF-1 on the phorbol ester and cAMP modulation of HUVEC PAI-1 expression. The phorbol ester PMA induced an approximate 5-fold increase in PAI-1 mRNA levels at 4 h, which returned to base line by 20 h, with or without HBGF-1 present in the media. This increase in PAI-1 mRNA levels was mediated by an increase in PAI-1 gene transcription and was abated in the presence of cycloheximide. Treatment of cells with the adenylate cyclase activator forskolin or the phosphodiesterase inhibitor HL 725, in the presence of HBGF-1 or immediately after its withdrawal, decreased PAI-1 mRNA levels and protein secreted into the conditioned media by 20 h. However, forskolin or HL 725 addition had little or no effect on PAI-1 mRNA when added 20 h after HBGF-1 withdrawal. Both the PMA and HBGF-1 modulation of PAI-1 were abolished by treatment with the protein kinase inhibitor H-7. Treatment of HUVEC with HBGF-1 had no acute effect on intracellular inositol phosphate hydrolysis or cAMP levels. Further studies on intracellular pathways involved in HBGF-1 modulation of PAI-1 will enhance our understanding of the role these factors play in cellular proliferation and angiogenesis.

摘要

纤溶酶原激活物抑制剂-1(PAI-1)可抑制组织纤溶酶原激活物(tPA)以及纤溶酶原向纤溶酶的尿激酶激活过程,纤溶酶是一种具有胰蛋白酶样特异性的蛋白酶,参与包括纤维蛋白溶解、基质降解和血管生成在内的多种过程。佛波酯和提高cAMP的化合物已被证明可在内皮细胞培养中调节PAI-1和tPA的表达。HBGF-1(先前称为内皮细胞生长因子)可在体外刺激内皮细胞生长,在体内具有血管生成作用。我们曾报道,从人脐静脉内皮细胞(HUVEC)培养基中去除HBGF-1会导致PAI-1 mRNA水平增加约5倍,并且到20小时时分泌到培养基中的PAI-1蛋白也增加。在此我们报告HBGF-1对HUVEC中PAI-1表达的佛波酯和cAMP调节的影响。佛波酯PMA在4小时时使PAI-1 mRNA水平增加约5倍,无论培养基中是否存在HBGF-1,到20小时时均恢复到基线水平。PAI-1 mRNA水平的这种增加是由PAI-1基因转录增加介导的,并且在存在环己酰亚胺的情况下会减弱。在存在HBGF-1时或在其撤除后立即用腺苷酸环化酶激活剂福斯可林或磷酸二酯酶抑制剂HL 725处理细胞,可使PAI-1 mRNA水平以及到20小时时分泌到条件培养基中的蛋白减少。然而,在HBGF-1撤除20小时后添加福斯可林或HL 725对PAI-1 mRNA几乎没有影响。用蛋白激酶抑制剂H-7处理可消除PMA和HBGF-1对PAI-1的调节作用。用HBGF-1处理HUVEC对细胞内肌醇磷酸水解或cAMP水平没有急性影响。对参与HBGF-1调节PAI-1的细胞内途径的进一步研究将增进我们对这些因子在细胞增殖和血管生成中所起作用的理解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验